Vident Advisory, LLC Alector, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 33,978 shares of ALEC stock, worth $156,978. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,978
Previous 22,011
54.37%
Holding current value
$156,978
Previous $133 Million
16.42%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALEC
# of Institutions
165Shares Held
58.1MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$24.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$21.4 Million0.69% of portfolio
-
Morgan Stanley New York, NY3.01MShares$13.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.79MShares$12.9 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $381M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...